Management reshuffle at Affimed
This article was originally published in Scrip
Executive Summary
Affimed Therapeutics, a therapeutic antibody company, has reorganised its management team under the leadership of Dr Adi Hoess, now CEO, and Dr Rolf Guenther, now COO. Dr Hoess was previously the company's chief commercial officer, while Dr Guenther was previously CEO. The company believes this reorganisation will support its new strategy to drive its projects into later stage development.